Parvin Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.03M Sell
5,619
-120
-2% -$41.1K 1.6% 10
2026
Q1
$2.02M Buy
5,739
+95
+2% +$33.9K 1.46% 12
2025
Q4
$1.85M Buy
5,644
+170
+3% +$53.9K 1.47% 12
2025
Q3
$1.54M Sell
5,474
-121
-2% -$35.1K 1.35% 13
2025
Q2
$1.56M Sell
5,595
-39
-0.7% -$11K 1.57% 10
2025
Q1
$1.76M Buy
5,634
+49
+0.9% +$14.5K 1.92% 8
2024
Q4
$1.46M Buy
+5,585
New +$1.66M 1.54% 12

Other funds holding AMGN

Parvin Asset Management's AMGN Position: Q2 2026 in Review

Parvin Asset Management reduced its Amgen (AMGN) stake by 2.1% in Q2 2026, selling an estimated $41.1K and leaving 5,619 shares worth $2.03M. The position accounts for 1.6% of the portfolio, ranked #10.

Parvin Asset Management first reported a position in AMGN in Q4 2024 and has held it in 7 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Parvin Asset Management held 5,619 shares of Amgen worth $2.03M as of Q2 2026.
  • Parvin Asset Management sold 120 Amgen shares in Q2 2026, an estimated $41.1K.
  • Amgen made up 1.6% of Parvin Asset Management's portfolio in Q2 2026, its #10 holding.
  • Parvin Asset Management first reported a position in Amgen in Q4 2024 and has held it in 7 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Parvin Asset Management's 13F filing for Q2 2026, filed 17 Aug 2026.